GlobeNewswire Inc.··Not SpecifiedUpstream Bio to Present Pipeline Progress at Major Healthcare Conferences
Upstream Bio will present pipeline progress at two March 2026 healthcare conferences, discussing its TSLP receptor antagonist in Phase 2 trials for severe respiratory conditions.
UPBinvestor conferenceverekitug